AMRX
AMRX clinical trials: Amneal Pharmaceuticals, Inc.
Every trial on ClinicalTrials.gov where Amneal Pharmaceuticals, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 20
- Trials linked
- 16
- As lead sponsor
- 4
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
AMRX on the catalyst calendar · AMRX registry changes
- Primary completion Mar 31, 2027Sponsor estimatePhase 3NCT07898072Safety and Efficacy of Weekly Testosterone Cypionate Auto-Injector in Men With HypogonadismAmneal Pharmaceuticals, LLC · Male HypogonadismRecruitingAMRXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 8, 2024ActualPhase 1NCT06467201SAD Study to Evaluate Safety, Tolerability, and Pharmacokinetic Profile of AMN1126 in Healthy Post-Menopausal FemalesAmneal Pharmaceuticals, LLC · Healthy Postmenopausal WomenCompletedAMRXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 1, 2025Sponsor estimatePhase 1NCT06267274A Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Clinical Endpoint in the...Amneal Pharmaceuticals, LLC · Open-angle GlaucomaUnknown statusAMRXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2022Sponsor estimatePhase 3NCT05401357Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGAN® in the Treatment of Chronic...Amneal Pharmaceuticals, LLC · Glaucoma, Open-AngleRecruitingAMRXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 2014ActualPhase 3NCT02121002Study Comparing a Generic Diclofenac Sodium Topical Gel, 1% to Voltaren in the Treatment of Subjects With Osteoarthritis of the KneeAmneal Pharmaceuticals, LLC · OsteoarthritisCompletedAMRXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 2, 2019ActualPhase 3NCT03562949A BE Study to Compare Beclomethasone Dipropionate Inhalation Aerosol, 40 mcg and QVAR® 40 mcg, Inhalation AerosolAmneal Ireland Limited · AsthmaTerminatedAMRXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 2019Sponsor estimatePhase 3NCT03562923A Study to Compare Fluticasone Propionate 100mcg/Salmeterol 50 mcg Inhalation Powder to Advair Discus 100/50Amneal Ireland Limited · AsthmaUnknown statusAMRXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 2018Sponsor estimatePhase 3NCT03549897Bronchoprovocation Study to Evaluate the Pharmacodynamics of Albuterol Sulfate Inhalation Aerosol, eq 90 mcg BaseAmneal Ireland Limited · AsthmaUnknown statusAMRXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 2016Sponsor estimatePhase 1NCT02940561BE Study in Patients - Methotrexate TabletsAmneal Pharmaceuticals, LLC · PsoriasisUnknown statusAMRXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 2014ActualPhase 3NCT02125253Study to Compare the Therapeutic Equivalence of Mometasone Furoate Nasal Spray, 50 mcg With Nasonex Nasal Spray in the Relief of the...Amneal Pharmaceuticals, LLC · Seasonal Allergic RhinitisCompletedAMRXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 2014ActualPhase 3NCT02110368Bioequivalence Study of Test and Reference Testosterone Topical Gel, 1.62% Metered Pump in Testosterone Deficient Adult Male Subjects...Amneal Pharmaceuticals, LLC · Primary HypogonadismCompletedAMRXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 2014ActualPhase 2/Phase 3NCT02103322Comparative Bioequivalence Study in Adult Patients Suffering From Chronic Myeloid Leukemia & Gastrointestinal Stromal Tumor Under Fed...Amneal Pharmaceuticals, LLC · Chronic Myeloid LeukemiaCompletedAMRXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 2014ActualPhase 2/Phase 3NCT02072954Bioequivalence Fasting Study in PatientsAmneal Pharmaceuticals, LLC · SchizophreniaCompletedAMRXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 2012ActualPhase 3NCT01779947Study to Evaluate the Safety and Bioequivalence of Estradiol Vaginal Inserts, 10 mcg and Vagifem® 10 mcg and Compare to PlaceboAmneal Pharmaceuticals, LLC · Atrophic Vaginitis Due to MenopauseCompletedAMRXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 2013ActualPhase 3NCT01650051Safety and Efficacy of Phenazopyridine Hydrochloride Tablets, USP 200 mg as an Analgesic for Short-Term Treatment in Female Subjects...Amneal Pharmaceuticals, LLC · Uncomplicated Urinary Tract InfectionsCompletedAMRXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2010ActualPhase 3NCT01064024Evaluate the Safety and Efficacy of Phenazopyridine Hydrochloride Tablets, USP 200 mg vs. PlaceboAmneal Pharmaceuticals, LLC · PainCompletedAMRXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 2099Sponsor estimateNo phase registeredNCT00404989Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry...Syneos Health · HIV Infections
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 15, 2027Sponsor estimatePhase 4NCT07138560BOOST-PD A Naturalistic Study on IPX-203 for Parkinson's DiseaseThe Cleveland Clinic · Parkinson DiseaseRecruitingAMRXCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 27, 2026ActualNo phase registeredNCT01733082The Mycophenolate Pregnancy RegistryGenentech, Inc. · Heart Transplantation, Kidney Transplantation, Liver Transplantation, Autoimmune DiseasesCompletedAMRXCollaboratorNVSCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 2025Sponsor estimatePhase 4NCT06765668A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's DiseaseImpax Laboratories, LLC · Parkinson DiseaseRecruitingAMRXCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 20 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner